Blood Transfusion at the Millennium Harvey G. Klein, M.D. Chief, Department of Transfusion Medicine Warren Grant Magnuson Clinical Center

The millennium brings exciting challenges for blood transfusion. Human blood substitutes, inactivating blood-borne infections, and using new blood components for gene therapy are but a few.

Tonight, Dr. Harvey G. Klein, Chief of the Clinical Centerís Department of Transfusion Medicine, will explain more about these challengesóand opportunities. He is a recognized leader in defining transfusion medicine as a broad-based clinical and laboratory consultative subspecialty.

A native of Boston, Dr. Klein graduated from Harvard College and earned his medical degree from The Johns Hopkins School of Medicine. He did his internship and residency at The Johns Hopkins University Hospital, where he was also a Fellow in Hematology.

Dr. Klein came to NIH in 1973 as a member of the Public Health Service Commissioned Officer Corps serving the National Heart, Lung, and Blood Institute. He joined the Clinical Center Blood Bank in 1975, holding various leadership positions until he became its Chief in 1983.

Through his stewardship, the Blood Bank evolved into the Department of Transfusion Medicine, the first of its kind in the country.

Dr. Klein has published widely, authoring or coauthoring more than 150 publications, including journal articles and book chapters on transfusion medicine in major textbooks on hematology, internal medicine, and blood banking. He is on the editorial boards of Transfusion and Transfusion Medicine Reviews.

He actively holds and has held leadership positions in many professional organizations, including the American Association of Blood Banks, the American Blood Commission, the American Society of Hematology, and the Amer-ican Society for Apheresis. Currently, he serves on the board of directors for the Chesapeake and Potomac blood program of the American National Red Cross and as Chairman of the Committee of Revision for Blood and Blood Products for the U.S. Pharmacopeia.

Dr. Klein is a diplomate of the American Board of Internal Medicine in the boardís hematology subspecialty, and a diplomate of the American Board of Pathology, blood bank specialty.

He has been an invited speaker at national and international symposia and has held named lectureships at Yale University, Montefiore Medical Center, and Cedars-Sinai Medical Center. This year, he is a Distinguished Visiting Professor of Pathology at The Johns Hopkins School of Medicine.

Throughout his career, Dr. Klein has received numerous awards, including a Meritorious Service Medal from the Public Health Service, an NIH Clinical Center Directorís Award, and most recently, the Cohn deLaval Medal from the World Apheresis Association. 

For more information about the Clinical Center and its Medicine for the Public lecture series, contact CC Communications (OCCC@nih.gov), (301) 496-2563. National Institutes of Health, Warren Grant Magnuson Clinical Center, Bethesda, Maryland 20892. 7/99 99 Series | CC home | NIH home